Liver cancer |
Tumor promoter |
Hep3B, SNU-387, Li-7, SMMC-7721, HepG2, Huh7, and HCC-LM3 |
Cell proliferation, apoptosis, migration, and invasion |
miR-29c, BMP1, miR-455-5p, and PD-L1 |
[23–25] |
Glioma |
Tumor promoter |
LN229, U251, SNB19, U87, U138, and H4 |
Cell proliferation, apoptosis, and migration |
miR-455-5p, and USP3 |
[25, 27] |
Lung cancer |
Tumor promoter |
A549, PC-9, NCI-H358, and NCI-H1299 |
Cell proliferation, migration, invasion, cisplatin resistance |
HOXA3, NF110, and HOXA6 |
[28–30] |
Oral cancer |
Tumor promoter |
TSCCA, CAL-27, SCC-9, and Tca8113 |
Cell proliferation |
miR-218-5p |
[31] |
Colorectal cancer |
Tumor promoter |
SW480, SW620, HCT116, COLO205, and LOVO |
Cell proliferation, and apoptosis |
miR-4319, SPNS2, and AKT |
[32] |
Gastric cancer |
Tumor promoter |
MGC-803, AGS, MKN45, SGC7901, and HGC-27 |
Cell proliferation, migration, and invasion |
miR-29a-3p, and LTβR |
[33] |
Pancreatic cancer |
Tumor promoter |
Panc-1, Aspc-1, sw1990, and Bxpc-3 |
Cell proliferation |
miR-29c, and CDK6 |
[34] |
Atherosclerosis |
– |
HUVECs |
Endothelium inflammation, cell proliferation, and apoptosis |
NF-κB, miR-455-5p, p27, and Kip1 |
[34, 37] |
Pulmonary arterial hypertension |
– |
HPASMCs |
Cell proliferation, apoptosis, migration, and invasion |
miR-675-3p, and PDE5A |
[38] |
MSCs lineage determination |
– |
MSCs |
Osteogenic differentiation |
EZH2, and RUNX2 |
[39] |